Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruiting
National Cancer Institute (NCI)
Phase 2
2020-05-13
This phase II trial studies how well duvelisib on an intermittent (irregular) dosing schedule
works in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell
growth. Giving duvelisib on an intermittent schedule may result in similar effectiveness with
less amount of severe side effects.
Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruiting
City of Hope Medical Center
Phase 2
2020-05-13
This phase II trial studies how well duvelisib on an intermittent (irregular) dosing schedule
works in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell
growth. Giving duvelisib on an intermittent schedule may result in similar effectiveness with
less amount of severe side effects.
Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruiting
OHSU Knight Cancer Institute
Phase 2
2020-05-13
This phase II trial studies how well duvelisib on an intermittent (irregular) dosing schedule
works in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell
growth. Giving duvelisib on an intermittent schedule may result in similar effectiveness with
less amount of severe side effects.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.